Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

1(13%)

Results Posted

0%(0 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_1

25%

Ph phase_3

63%

Ph phase_2

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

2(25.0%)

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(1)

Other(1)

Detailed Status

Completed5

Recruiting1

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (25.0%)

Phase 21 (12.5%)

Phase 35 (62.5%)

Trials by Status

recruiting113%

terminated113%

unknown113%

completed563%

Recent Activity

1 active trials

Showing 5 of 8

terminatedphase_3

Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

NCT03765541

completedphase_2

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

NCT01228331

recruitingphase_1

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

NCT05807932

unknownphase_3

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

NCT00002658

completedphase_3

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

NCT00003436

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT03765541Phase 3

Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

Terminated

NCT01228331Phase 2

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

Completed

NCT05807932Phase 1

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Recruiting

NCT00002658Phase 3

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Unknown

NCT00003436Phase 3

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

Completed

NCT01324063Phase 3

A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)

Completed

NCT00002719Phase 3

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

Completed

NCT00840684Phase 1

Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8